Category: Federal Forum Posters
Purpose: Utilization of oral chemotherapy medications has been increasing over the past several decades. The increased utilization of oral medications over traditional intravenous chemotherapy is related to the convenience it may provide to a patient. Although more convenient, oral regimens can be complex and may cause confusion leading to decreased medication adherence. With patient’s having more control over their treatment, this has led to an increased need for oversight for patients taking oral chemotherapy medications. The purpose of this project is to describe the practice and role of a pharmacist in a pharmacist-run oral chemotherapy clinic.
Methods: This descriptive, retrospective chart review project will be submitted to the Veterans Affairs research staff and leadership for approval. The electronic medical record system will identify chemotherapy patients on oral antineoplastic agents. The medical record review period will begin from April 1, 2018 to September 30, 2018. The following data will be collected: patient age, gender, ethnicity, height, weight, cancer diagnosis, comorbidities, chemotherapy agents utilized, total number of medications, duration of chemotherapy, reported side effects, and number and type of interventions made. All data will be recorded without patient identifiers and maintained confidentially. The primary outcome is to determine the number of interventions made by an oncology pharmacist per patient visit for oral chemotherapy medications. Secondary outcomes are to describe the types of oral oncology medication(s) patients are on, and the number and type of adverse drug reactions that a patient experiences with oral chemotherapy medications.
Results: Not applicable
Conclusion: Not applicable
Emily Hailstone– PGY2 Health-System Administration Pharmacy Resident, Ralph H. Johnson VA Medical Center, Wetumpka, AL